home / stock / pear / pear news


PEAR News and Press, Pear Therapeutics Inc. From 06/15/22

Stock Information

Company Name: Pear Therapeutics Inc.
Stock Symbol: PEAR
Market: NASDAQ

Menu

PEAR PEAR Quote PEAR Short PEAR News PEAR Articles PEAR Message Board
Get PEAR Alerts

News, Short Squeeze, Breakout and More Instantly...

PEAR - Pear Therapeutics Announces Three New Board Members

New Board Members Paul Mango, Shiva Rajaraman, and Tim Wicks bring a depth of experience and knowledge in both the healthcare and technology industries Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines calle...

PEAR - Pear Therapeutics rises as study shows opioid use disorder therapy reduces inpatient stays

Pear Therapeutics (NASDAQ:PEAR) said on Tuesday that results from a 12-month data study of reSET-O, its PDT for the treatment of opioid use disorder (OUD), showed a reduction in healthcare utilization, particularly inpatient stays and emergency department visits. (PEAR) rose ~9% ...

PEAR - Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

reSET-O ® is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of opioid use disorder (OUD) Results support the real-world value of reSET-O, demonstrating durable treatment outcomes and reductions in healthcare resource utilization ...

PEAR - Pear says trial shows Somryst significantly reduces insomnia, anxiety, depression

Pear Therapeutics (NASDAQ:PEAR) is trading ~6% higher premarket after the company said on Wednesday an interim follow-up trial showed its FDA-authorized therapy, Somryst, achieved significant reductions in symptoms of insomnia, anxiety and depression severity both immediately following treatm...

PEAR - Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022

Interim results from the DREAM trial showed treatment with Somryst, a prescription digital therapeutic (PDT) for patients with chronic insomnia, achieved significant reductions in symptoms of insomnia, anxiety and depression severity through six months 1 New real...

PEAR - CTSO, LIDR and UONE among mid-day movers

Gainers: Aero Clean Technologies AERC +49%. Houston American Energy (HUSA) +37%. Jan One JAN +37%. Oncorus (ONCR) +41%. Cytosorbents  (CTSO) +33%. Mirati Therapeutics MRTX +30%. Omega (OMGA) +27%. Codiak BioSciences (CDAK) +27%. Quantum Computing (QUBT) +26%. GitLab GTLB&#...

PEAR - VIEW, UONE and STRY among mid-day movers

Gainers: Aero Clean Technologies (AERC) +58%. DiDi Global (DIDI) +39%. Yumanity Therapeutics (YMTX) +31%. Pineapple Energy (PEGY) +25%. View (VIEW) +26%. ATIF Holdings (ATIF) +26%. The Arena Group Holdings (AREN) +25%. Cerberus Cyber Sentinel (CISO) +23%. FTC Solar (FTCI) +23%. Kanzhun (BZ) +...

PEAR - Yumanity, Babylon top healthcare gainers; while Praxis, eFFECTOR lead losers' pack

Gainers:  Yumanity Therapeutics YMTX +46%. Babylon (BBLN) +11%. Sema4 (SMFR) +11%. Nano-X Imaging (NNOX) +10%. Satsuma Pharmaceuticals (STSA) +10%. Losers: Praxis Precision Medicines PRAX -63%. eFFECTOR Therapeutics (EFTR) -20%. Pear Therapeutics (PEAR) ...

PEAR - Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months

reSET ® is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of substance use disorder (SUD), including alcohol, cannabis, cocaine, and stimulants Results support the real-world value of reSET, demonstrating durable treatment o...

PEAR - Catalyst watch: Apple's WWDC, Nio earnings, eyes on AMD, Spotify & Hyzon events

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Previous 10 Next 10